Hong DS, Garrido-Laguna I, Ekmekcioglu S, Falchook GS, Naing A, Wheler JJ, Fu S, Moulder SL, Piha-Paul S, Tsimberidou AM, Wen Y, Culotta KS, Anderes K, Davis DW, Liu W, George GC, Camacho LH, Percy Ivy S, Kurzrock R. “Dual Inhibition of the Vascular Endothelial Growth Factor Pathway: A Phase 1 Trial Evaluating Bevacizumab and AZD2171 (cediranib) in Patients with Advanced Solid Tumors.” Cancer 120(14), 2164-2173. July 2014.2013

Learn More